Utility of Routine Testing for Patients With Asymptomatic Severe Blood Pressure Elevation in the Emergency Department
Study objective
Recommendations for the treatment of emergency department (ED) patients with asymptomatic severely elevated blood pressure advise assessment for occult, acute hypertensive target-organ damage. This study determines the prevalence of unanticipated, clinically meaningful test abnormalities in ED patients with asymptomatic severely elevated blood pressure.
Methods
This was a prospective observational study at 3 urban academic EDs. Consecutive patients with systolic blood pressure greater than or equal to 180 mm Hg or diastolic blood pressure greater than or equal to 110 mm Hg on 2 measurements were enrolled if they denied symptoms of hypertensive emergency. A basic metabolic panel, urinalysis, ECG, CBC count, and chest radiograph were obtained. Treating physicians were interviewed about the indication for each test and whether an abnormal result was anticipated according to clinical findings. When test results were available, physicians were asked whether abnormal findings were clinically meaningful, defined as leading to unanticipated hospitalization, medication modification, or further immediate evaluation. The primary outcome was the prevalence of unanticipated clinically meaningful test abnormalities.
Results
One hundred nine patients with asymptomatic severely elevated blood pressure were enrolled. Unanticipated abnormal test results were noted in 57 (52%) patients. Clinically meaningful unanticipated test abnormalities were found in 7 (6%) patients: basic metabolic panel in 2 (2%), CBC count in 3 (3%), urinalysis in 3 (4%), ECG in 2 (2%), and chest radiograph in 1 (1%). Five patients (5%) had abnormalities assessed as possible manifestations of acute hypertensive target-organ injury; none had abnormalities clearly related to severely elevated blood pressure.
Conclusion
Screening tests of urban ED patients with asymptomatic severely elevated blood pressure infrequently detect unanticipated hypertension-related abnormalities that alter ED management.
To access this article, please choose from the options below
Supervising editor: Judd E. Hollander, MDAuthor contributions: DJK, JJC, JWU, PS, and KLH conceived the study and designed the protocol. DJK and LKK wrote the article. LKK performed the statistical analyses and has expertise in these procedures. DAW, MMW, and JJC supervised data collection. All authors participated substantially in the article revision. DJK takes responsibility for the paper as a whole.Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that may create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. This study was funded by an unrestricted research grant from Pfizer, Inc. The sponsor had no role in the study design; in the collection, management, analysis, or interpretation of data; or in the preparation, review, or approval of the article.Publication dates: Available online May 11, 2007.Earn CME Credit: Continuing Medical Education for this article is available at: www.ACEP-EMedHome.com.Reprints not available from the authors.
PII: S0196-0644(07)00439-8
doi:10.1016/j.annemergmed.2007.03.032
© 2008 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
